🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

14 recruiting trials

for Advanced Gynecological Malignancy

A Clinical Trial of TQB2102 for Injection in Gynecological Tumors With Recurrent/Metastatic Advanced NCT06798207Phase 231 sites📍 Beijing📍 Chongqing📍 Fuzhou Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Phar… · Tests: TQB2102 for injection Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers NCT06906341Phase 249 sites📍 Birmingham📍 Palo Alto📍 San Francisco Corcept Therapeutics · Tests: Relacorilant 150 mg once daily (QD), Nab-paclitaxel 80 mg/m^2, Bevacizumab 10 mg/kg Gut Microbiome and Treatment for Gynecological Cancer Patients Receiving Immunotherapy NCT04957511n/a1 site📍 Orlando Viome Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS NCT05379985Phase 1, Phase 221 sites📍 Orange📍 Santa Monica📍 Tampa Revolution Medicines, Inc. · Tests: RMC-6236 A Phase I Clinical Trial of CAR-T Cells for Advanced Gynecological Solid Tumors NCT06904131NA1 site📍 Shanghai Obstetrics & Gynecology Hospital of Fudan University · Tests: Cell therapy with bispecific antibodies A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tumors (BEHOLD-2) NCT06796907Phase 1, Phase 282 sites📍 La Jolla📍 Aurora📍 Rochester GlaxoSmithKline · Tests: Mo-Rez, Dostarlimab, Bevacizumab Study to Assess the Safety and Effects of Porphysome Nanoparticles for Imaging in Gynaecological Cancers NCT06977126Phase 11 site📍 Toronto University Health Network, Toronto · Tests: PORPHYSOMES, 64Cu-PORPHYSOMES A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX43 (Anti-PD-L1 ADC) in Patients With Advanced Gynecological Malignant Tumors NCT06769152Phase 21 site📍 Ji'nan Shanghai Henlius Biotech · Tests: HLX43 Ontario-wide Cancer TArgeted Nucleic Acid Evaluation NCT02906943n/a7 sites📍 Hamilton📍 Kingston📍 London University Health Network, Toronto Advanced Radiotherapy (ART) in Gynecological Cancer Patients (GYN-ART) NCT06306170n/a1 site📍 Milan IRCCS San Raffaele · Tests: Image Guided Radiotherapy Exploratory Clinical Study of cCTL in Combination With Immunotherapy for Advanced Gynecologic Malignancies NCT07434284EARLY Phase 11 site📍 Shanghai Obstetrics & Gynecology Hospital of Fudan University · Tests: cCTL treatment Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors NCT06128551Phase 1, Phase 256 sites📍 Duarte📍 Orange📍 Sacramento Revolution Medicines, Inc. · Tests: Elironrasib, Daraxonrasib A Study of SKB518 as Monotherapy or Combination Therapy in Patients With Advanced Gynecological Malignant Tumors NCT07448922Phase 22 sites📍 Chongqing📍 Shanghai Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Tests: SKB518 for injection, Carboplatin (AUC 5), Bevacizumab, SKB518 for injection A Trial of SHR-A2102 for Treatment of Advanced Gynecological Malignancy NCT06654440Phase 21 site📍 Guangzhou Shanghai Hengrui Pharmaceutical Co., Ltd. · Tests: SHR-A2102 for injection
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy